Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2013

01-08-2013 | Erratum

Erratum to: DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study

Authors: Meng Hua Tao, Peter G. Shields, Jing Nie, Amy Millen, Christine B. Ambrosone, Stephen B. Edge, Shiva S. Krishnan, Catalin Marian, Bin Xie, Janet Winston, Dominica Vito, Maurizio Trevisan, Jo L. Freudenheim

Published in: Breast Cancer Research and Treatment | Issue 1/2013

Login to get access

Excerpt

Unfortunately, in the original publication of the article, the grant number in the funding information has been published incorrectly. The correct funding information should be “This work was funded by United States Public Health Service (USPHS) Grant Number R01CA092040 from the National Cancer Institute, and #DAMD 17030446 and #DAMD 179616202 from the DOD”. …
Metadata
Title
Erratum to: DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study
Authors
Meng Hua Tao
Peter G. Shields
Jing Nie
Amy Millen
Christine B. Ambrosone
Stephen B. Edge
Shiva S. Krishnan
Catalin Marian
Bin Xie
Janet Winston
Dominica Vito
Maurizio Trevisan
Jo L. Freudenheim
Publication date
01-08-2013
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2013
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-013-2660-5

Other articles of this Issue 1/2013

Breast Cancer Research and Treatment 1/2013 Go to the issue

Epidemiology

Disease-free survival by treatment after a DCIS diagnosis in a population-based cohort study

Review

Paget’s disease of the nipple

Preclinical Study

Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK–mTORC1 signaling

Brief Report

Trends and clinical implications of preoperative breast MRI in Medicare beneficiaries with breast cancer

Epidemiology

Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests

Review

The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits